Commission Implementing Regulation (EU) 2017/1376 of 25 July 2017 renewing the approval of warfarin as an active substance for use in biocidal products of product-type 14 (Text with EEA relevance. )
Article 2
In force · version of Aug 15, 2017
Implementing Decision (EU) 2016/135 is repealed.